Cancer cachexia: mechanisms and clinical implications CL Donohoe, AM Ryan, JV Reynolds Gastroenterology research and practice 2011 (1), 601434, 2011 | 366 | 2011 |
Visceral obesity, metabolic syndrome, insulin resistance and cancer SL Doyle, CL Donohoe, J Lysaght, JV Reynolds Proceedings of the Nutrition Society 71 (1), 181-189, 2012 | 344 | 2012 |
Visceral adiposity, insulin resistance and cancer risk CL Donohoe, SL Doyle, JV Reynolds Diabetology & metabolic syndrome 3, 1-13, 2011 | 286 | 2011 |
Obesity and gastrointestinal cancer CL Donohoe, GP Pidgeon, J Lysaght, JV Reynolds Journal of British Surgery 97 (5), 628-642, 2010 | 178 | 2010 |
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) JV Reynolds, SR Preston, B O’neill, L Baeksgaard, SM Griffin, C Mariette, ... BMC cancer 17, 1-10, 2017 | 177 | 2017 |
Establishing computed tomography–defined visceral fat area thresholds for use in obesity-related cancer research SL Doyle, AM Bennett, CL Donohoe, AM Mongan, JM Howard, ... Nutrition Research 33 (3), 171-179, 2013 | 177 | 2013 |
Emerging concepts linking obesity with the hallmarks of cancer CL Donohoe, J Lysaght, J O'Sullivan, JV Reynolds Trends in Endocrinology & Metabolism 28 (1), 46-62, 2017 | 135 | 2017 |
IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity SL Doyle, CL Donohoe, SP Finn, JM Howard, FE Lithander, JV Reynolds, ... Official journal of the American College of Gastroenterology| ACG 107 (2 …, 2012 | 128 | 2012 |
Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments J O’Sullivan, J Lysaght, CL Donohoe, JV Reynolds Nature reviews Gastroenterology & hepatology 15 (11), 699-714, 2018 | 123 | 2018 |
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment C Hayes, CL Donohoe, M Davern, NE Donlon Cancer letters 500, 75-86, 2021 | 112 | 2021 |
Short bowel syndrome CL Donohoe, JV Reynolds The surgeon 8 (5), 270-279, 2010 | 109 | 2010 |
Long-term health-related quality of life for disease-free esophageal cancer patients CL Donohoe, E McGillycuddy, JV Reynolds World journal of surgery 35, 1853-1860, 2011 | 103 | 2011 |
Fast-track protocols in colorectal surgery CL Donohoe, M Nguyen, J Cook, SG Murray, N Chen, F Zaki, BJ Mehigan, ... The surgeon 9 (2), 95-103, 2011 | 103 | 2011 |
Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard CL Donohoe, NJ O'Farrell, T Grant, S King, L Clarke, C Muldoon, ... Annals of Surgery 258 (5), 784-792, 2013 | 94 | 2013 |
Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue J Lysaght, EP Van Der Stok, EH Allott, R Casey, CL Donohoe, JM Howard, ... Cancer letters 312 (1), 62-72, 2011 | 90 | 2011 |
New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short-and long-term outcomes O Mc Cormack, A Zaborowski, S King, L Healy, C Daly, N O'Farrell, ... Annals of surgery 260 (5), 772-778, 2014 | 81 | 2014 |
Advances in the curative management of oesophageal cancer JC Bolger, CL Donohoe, M Lowery, JV Reynolds British Journal of Cancer 126 (5), 706-717, 2022 | 66 | 2022 |
The role of obesity in gastrointestinal cancer: evidence and opinion CL Donohoe, NJ O’Farrell, SL Doyle, JV Reynolds Therapeutic advances in gastroenterology 7 (1), 38-50, 2014 | 66 | 2014 |
Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer? HM Heneghan, C Donohoe, J Elliot, Z Ahmed, V Malik, N Ravi, ... Annals of surgery 264 (5), 831-838, 2016 | 59 | 2016 |
Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma CL Donohoe, SL Doyle, S McGarrigle, MC Cathcart, E Daly, A O'Grady, ... Journal of British Surgery 99 (3), 387-396, 2012 | 59 | 2012 |